Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Sensitive Tumor”

268 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 268 results

Not applicableStudy completedNCT03917147
What this trial is testing

Correlation Between Hysteroscopic Diagnosis of Endometrial Hyperplasia and Histopathological Examination

Who this might be right for
Endometrial HyperplasiaEndometrial Neoplasms
University of Campania Luigi Vanvitelli 435
Not applicableLooking for participantsNCT06573723
What this trial is testing

Institutional Registry of Rare Diseases

Who this might be right for
Rare DiseasesAmyloidosisSarcoidosis+23 more
Hospital Italiano de Buenos Aires 380
Not applicableWithdrawnNCT02458482
What this trial is testing

Trial of AccuPAP Device Versus Standard Nebulizer Therapy in Acute Asthma Exacerbation in Children

Who this might be right for
Asthma
Vanderbilt University Medical Center
Not applicableStudy completedNCT02844842
What this trial is testing

Evaluation of Tolerability and Safety of "Allergovac Poliplus" in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice

Who this might be right for
Allergic RhinitisRhinoconjunctivitisAsthma
Roxall Medicina España S.A 152
Testing effectiveness (Phase 2)Ended earlyNCT00929162
What this trial is testing

ZD4054 (Zibotentan) or Placebo Plus Chemotherapy in Patients With Advanced Ovarian Cancer

Who this might be right for
Patients With Advanced Ovarian Cancer Sensitive to Platinum-based Chemotherapy
AstraZeneca 120
Testing effectiveness (Phase 2)Study completedNCT01875250
What this trial is testing

Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 38
Not applicableNot Yet RecruitingNCT06630078
What this trial is testing

Artificial Intelligence-based Voice Assessment of Children and Adults Respiratory Conditions

Who this might be right for
Airway DiseaseCancer of Head and NeckRadiotherapy+2 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 200
Not applicableUnknownNCT03358992
What this trial is testing

Clinical Evaluation for Sarcoma Originated From Bone

Who this might be right for
SensitivitySpecificityHistological Response+1 more
Peking University People's Hospital 300
Large-scale testing (Phase 3)Study completedNCT00312845
What this trial is testing

Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Millennium Pharmaceuticals, Inc. 676
Not applicableUnknownNCT05001386
What this trial is testing

In Vitro Drug Sensitivity Testing of Fresh Human Samples

Who this might be right for
Myeloproliferative DisordersLymphoproliferative Disorders
Hospices Civils de Lyon 800
Early research (Phase 1)Ended earlyNCT03432741
What this trial is testing

Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer

Who this might be right for
Breast AdenocarcinomaMetastatic Breast CarcinomaRecurrent Breast Carcinoma+11 more
Mayo Clinic 17
Testing effectiveness (Phase 2)Looking for participantsNCT05915442
What this trial is testing

Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer

Who this might be right for
Oligometastatic Prostate Cancer
Catherine Spina 23
Testing effectiveness (Phase 2)Looking for participantsNCT05284539
What this trial is testing

Efficacy of Platinum-based Chemotherapy Plus Immune Checkpoint Inhibitors for EGFR/ALK/ROS1 Mutant Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Hunan Province Tumor Hospital 760
Not applicableStudy completedNCT01837693
What this trial is testing

Cervical Cancer Prevention: From DNA to mRNA? - New Technologies for Cervical Cancer Screening 2

Who this might be right for
Precancerous ConditionsNeoplasms
Azienda USL Reggio Emilia - IRCCS 41,127
Not applicableLooking for participantsNCT07189806
What this trial is testing

Longitudinal Phenotyping and Endotyping Study in Adult Patients With Mild, Moderate, or Severe Asthma

Who this might be right for
Asthma (Diagnosis)
Hvivo 250
Not applicableUnknownNCT05181202
What this trial is testing

Biomarkers of Liposomal Doxorubicin Induced Hypersensitivity Reaction in Breast Cancer Patients

Who this might be right for
Liposomal Doxorubicin Induced Hypersensitivity Reaction in Breast Cancer Patients
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 20
Testing effectiveness (Phase 2)Study completedNCT02105012
What this trial is testing

Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma

Who this might be right for
Asthma
Pearl Therapeutics, Inc. 147
Not applicableEnded earlyNCT03043898
What this trial is testing

Mapping Sound Propagation Through the Human Lung for Better Diagnosis

Who this might be right for
BronchomalaciaAsthmaLung Neoplasms+2 more
Maximilian Nussbaumer 62
Testing effectiveness (Phase 2)Ended earlyNCT05288062
What this trial is testing

Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma

Who this might be right for
Plasma Cell MyelomaRecurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma+1 more
Mayo Clinic 17
Testing effectiveness (Phase 2)WithdrawnNCT02126020
What this trial is testing

Topical Infliximab in Autoimmune Eyes With Keratoprosthesis

Who this might be right for
Stevens-Johnson SyndromeToxic Epidermal Necrolysis (Lyell) SyndromeMucous Membrane Pemphigoid
James Chodosh, MD, MPH
Load More Results